These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12852147)

  • 21. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.
    Roemeling S; Roobol MJ; Postma R; Gosselaar C; van der Kwast TH; Bangma CH; Schröder FH
    Eur Urol; 2006 Sep; 50(3):475-82. PubMed ID: 16713065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyper-elevated prostate-specific antigen levels are not always carcinoma.
    Lawrentschuk N; Davidson AJ; Hurley MR; Crowley PF; Bolton DM
    Br J Hosp Med (Lond); 2006 Mar; 67(3):152-3. PubMed ID: 16562445
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular markers of prostate cancer.
    Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for prostate cancer with prostate-specific antigen. An examination of the evidence.
    Woolf SH
    N Engl J Med; 1995 Nov; 333(21):1401-5. PubMed ID: 7477122
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
    Wymenga LF; Mensink HJ
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1733-8. PubMed ID: 10494319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic carcinoma.
    Lawton CA; Grignon D; Newhouse JH; Schellhammer PF; Kuban DA
    Radiographics; 1999; 19(1):185-203. PubMed ID: 9925399
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostate cancer in Czech Republic 1959-1992. Descriptive survey.
    Celko AM
    Cent Eur J Public Health; 1995 Aug; 3(3):119-23. PubMed ID: 8535365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen adjusted for total prostatic tumor volume as a predictor for outcome after radical prostatectomy.
    Hayashi N; Urashima M; Ikemoto I; Kuruma H; Arai Y; Kuwao S; Baba S; Egawa S
    Prostate Cancer Prostatic Dis; 2007; 10(1):60-5. PubMed ID: 17003775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prostate specific antigen (PSA): impact of a seric marker on the diagnosis and therapeutic management of cancers of the prostate].
    Chauvet B; Jacob T; Davin JL; Berger C; Vincent P; Reboul F
    Bull Cancer Radiother; 1996; 83(4):334-44. PubMed ID: 9081335
    [No Abstract]   [Full Text] [Related]  

  • 30. [PSA doubling times of prostate carcinoma managed with watchful observation alone].
    Dunst J
    Strahlenther Onkol; 2001 Dec; 177(12):684-5. PubMed ID: 11789411
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of prostate specific antigen in prostate cancer--prediction for treatment failure].
    Egawa S
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():100-6. PubMed ID: 12599553
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prostate-specific antigen: an evaluation 15 years after its discovery].
    Janssen T; Schulman C
    Prog Urol; 1994 Apr; 4(2):171-80. PubMed ID: 7515305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
    Etzioni RD; Ankerst DP; Thompson IM
    J Natl Cancer Inst; 2007 Mar; 99(6):489-90; author reply 490. PubMed ID: 17374841
    [No Abstract]   [Full Text] [Related]  

  • 34. [Incidental carcinoma of the prostate].
    Iavarone C; Felici A; Angelini E; Hadjiamiri H; Pulcini A; Messinetti S
    G Chir; 1992; 13(8-9):427-8. PubMed ID: 1384637
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prostate-specific antigen (PSA)].
    Huland H
    Urologe A; 1995 Jul; 34(4):273-4. PubMed ID: 7545840
    [No Abstract]   [Full Text] [Related]  

  • 36. Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?
    Raviv G; Zlotta AR; Janssen Th; Descamps F; Vanegas JP; Verhest A; Schulman CC
    Cancer; 1996 May; 77(10):2103-8. PubMed ID: 8640677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen.
    Cheng CW; Chan LW; Ng CF; Chan CK; Tse MK; Lai MM
    Int J Urol; 2006 Apr; 13(4):463-5. PubMed ID: 16734876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localized prostate cancer. Diagnosis and treatment.
    Bulbul MA
    J Med Liban; 1993; 41(4):218-22. PubMed ID: 7543154
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostate-specific antigen testing. An essential guide to its use and meaning.
    Marks SH
    Adv Nurse Pract; 2001 Apr; 9(4):38-9, 43-4. PubMed ID: 12420434
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of morphometric measurements of prostate carcinoma volume.
    Renshaw A
    Cancer; 2002 Apr; 94(8):2309-10. PubMed ID: 12001133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.